All Pharma articles – Page 19
-
-
CommentEnd Game: Lansley's parting policy potshots
He has no problem questioning the cancer drugs fund
-
NewsExclusive: HRA moves to stave off judicial review in clinical trial row
The Health Research Authority has moved to stave off a judicial review by a pharmaceutical company with links to the NHS in a dispute over transparency in clinical trials, HSJ has learned.
-
NewsExclusive: NHS England proposes new rare condition drug access rules
NHS England is set to publish new guidance, described by charities as ‘life saving’, on access to licensed drugs for patients with rare conditions and in ‘critical need’, HSJ has learned.
-
SupplementsRoundtable: Leading the way in developing new care models
The pros and cons of vanguard sites developing new care models
-
-
HSJ LocalOxford trust appoints new chief executive
WORKFORCE: Oxford University Hospitals Trust has appointed Dr Bruno Holthof as its chief executive.
-
HSJ LocalManchester commissioners to lobby over pharma deal money
FINANCE: Commissioners across Greater Manchester plan to lobby the government to ensure money given to the NHS by drug companies as part of a national pricing deal is available for use in the region.
-
NewsAstraZeneca president 'would not back pricing deal again'
The UK president of drug giant AstraZeneca has indicated she would not sign up to another deal similar to the current pharmaceutical pricing scheme unless the NHS makes a ‘substantial’ increase of drugs access.
-
NewsPolicy delays risk 'preventable deaths', doctors warn NHS England
Letter says rare conditions drug policy is a “matter of extreme urgency” Doctors warn patient access could be delayed until 2016-17 NHS England to set out timetable for new specialised commissioning process soon Twenty senior doctors and experts have written an open letter to the NHS England board ...
-
HSJ LocalPrivate ambulance provider investigated over security concerns
PERFORMANCE: A private ambulance provider used by an NHS trust in Kent is being investigated after an inspection found it was insecurely storing medicine at a hotel and employed staff who had not been security checked.
-
NewsMake drug shortages ‘never events’, say MPs
The next government has been urged to treat patient incidents caused by avoidable shortages in prescription medicines as ‘never events’ by a group of MPs.
-
NewsExclusive: NHS England labelled 'dysfunctional' over drug policy delay
NHS England has been accused of misleading government ministers and labelled a ‘dysfunctional organisation’ over delays in drawing up a prescribing policy for drugs to treat rare diseases.
-
NewsA&E pharmacists pilot gets national rollout
More than 50 pilot sites will take part in a national trial of clinical pharmacists in accident and emergency departments.
-
HSJ LocalBath praised for pharmacists in GP surgeries scheme
PRIMARY CARE: A mobile pharmacy team in Bath and North East Somerset that provides patients with access to a pharmacist’s expertise at their local GP has been praised by the Royal Pharmaceutical Society.
-
NewsPharma giant strikes deal to save breast cancer drug funding
The Swiss drug giant Novartis has struck a deal with NHS England to prevent one of its breast cancer treatments being axed from the cancer drugs fund.
-
NewsExclusive: NHS England drug delay led to ‘absolutely preventable’ deaths
A two year delay in NHS England drawing up a prescribing policy for a licensed drug has led to at least two ‘absolutely preventable’ deaths and more than 30 adults and children left at significant risk, HSJ has been told.
-
HSJ KnowledgeThought diversity is the lifeline for equality
The value of unlocking diversity of perspectives
-
NewsCancer drugs spared funding axe following appeals
Three drugs that NHS England said would be axed from the cancer drugs fund will remain available at least temporarily, following a series of appeals by drug companies.
-
SupplementsClinical research supplement: the future of trials in the NHS
Trial, trial and trial again